Teduglutide vs Linaclotide
Head-to-head comparison of Teduglutide (Teduglutide (glycyl-2 human glucagon-like peptide-2 analog)) and Linaclotide (Linaclotide) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Teduglutide | Linaclotide |
|---|---|---|
| Category | Gastrointestinal | Gastrointestinal |
| Full Name | Teduglutide (glycyl-2 human glucagon-like peptide-2 analog) | Linaclotide |
| Molecular Weight | 3752 Da | 1526.8 Da |
| Half-Life | approximately 2-3 hours | Active locally; negligible systemic half-life |
| Amino Acids | 33 | 14 |
| Typical Dose | 0.05 mg/kg/day | 72-290 mcg once daily |
| Route | Subcutaneous | Oral |
| Purity | ≥98% | ≥98% |
| Studies Count | 300 | 1200 |
| Research Status | Clinical | Clinical |
Teduglutide Benefits
- ✓mucosal-growth
- ✓absorption-support
- ✓barrier-repair
- ✓intestinal-adaptation
Linaclotide Benefits
- ✓improves-bowel-movements
- ✓reduces-abdominal-pain
- ✓increases-intestinal-secretion
- ✓supports-transit
Teduglutide Dosing
0.05 mg/kg once daily subcutaneous injection|chronic maintenance dosing in approved use|monitor fluid status and intestinal anatomy
Linaclotide Dosing
72 mcg PO daily|145 mcg PO daily|290 mcg PO daily
Teduglutide Side Effects
- ⚠abdominal pain
- ⚠fluid retention
- ⚠polyp/neoplasia monitoring needed
Linaclotide Side Effects
- ⚠diarrhea
- ⚠abdominal-pain
- ⚠bloating
Research Overview
Teduglutide
Teduglutide has robust clinical evidence showing improved intestinal absorption and reduced parenteral nutrition dependence in short bowel syndrome. Its mechanism, via GLP-2 receptor activation, makes it highly relevant to mucosal healing and intestinal adaptation research.
Linaclotide
Linaclotide has extensive clinical evidence for chronic idiopathic constipation and IBS-C, with consistent effects on stool frequency and abdominal symptom relief. Its mechanism is local GC-C activation in the gut with minimal systemic exposure.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.